著者: OgataHiroshi, KitamuraShigeki, FujiwaraMakoto, ShimizuMasaru, TanChengbo, ZhaoSongji, MaejimaYuko, ShimomuraKenju

原題: Dose Dependent Effect of Sulfamethoxazole on Inhibiting K_ATP Channel of Mouse Pancreatic β Cell.

著者: JulianaChristine A, ChaiJinghua, ArroyoPablo, Rico-BautistaElizabeth, BetzStephen F, De LeónDiva D

原題: A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism.

著者: SharmaAbhinav, PagidipatiNeha J, CaliffRobert M, McGuireDarren K, GreenJennifer B, DemetsDave, GeorgeJyothis Thomas, GersteinHertzel C, HobbsTodd, HolmanRury R, LawsonFrancesca C, LeiterLawrence A, PfefferMarc A, ReuschJane, RiesmeyerJeffrey S, RoeMatthew T, RosenbergYves, TempleRobert, WiviottStephen, McMurrayJohn, GrangerChristopher

原題: Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.

著者: SuroowanS, MahomoodallyM F

原題: Herbal Medicine of the 21st Century: A Focus on the Chemistry, Pharmacokinetics and Toxicity of Five Widely Advocated Phytotherapies.

著者: GuptaPrachi, BalaManju, GuptaSanjeev, DuaAnita, DaburRajesh, InjetiElisha, MittalAshwani

原題: Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action.

著者: LenuzzaNatacha, DuvalXavier, NicolasGrégory, ThévenotEtienne, JobSylvie, VideauOrianne, NarjozCéline, LoriotMarie-Anne, BeaunePhilippe, BecquemontLaurent, MentréFrance, Funck-BrentanoChristian, AlavoineLoubna, ArnaudPhilippe, DelaforgeMarcel, BénechHenri

原題: Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.

著者: ManakaKazunori, NakataMasanori, ShimomuraKenju, RitaRauza S, MaejimaYuko, YoshidaMasashi, DezakiKatsuya, KakeiMasafumi, YadaToshihiko

原題: Chronic exposure to valproic acid promotes insulin release, reduces KATP channel current and does not affect Ca (2+) signaling in mouse islets.

著者: LeeKye Sook, KimSang Kyum

原題: Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.

著者: ProtJean-Matthieu, VideauOrianne, BrochotCéline, LegallaisCécile, BénechHenri, LeclercEric

原題: A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening.

著者: WangB, WangJ, HuangS-Q, SuH-H, ZhouS-F

原題: Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.

著者: RafachoAlex, MarroquíLaura, TabogaSebastião R, AbrantesJúlia L F, SilveiraLeonardo R, BoscheroAntonio C, CarneiroEverardo M, BosqueiroJosé R, NadalAngel, QuesadaIvan

原題: Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets.

著者: ZhouShu-Feng, ZhouZhi-Wei, HuangMin

原題: Polymorphisms of human cytochrome P450 2C9 and the functional relevance.

著者: DiYuan Ming, LiChun Guang, XueCharlie Changli, ZhouShu-Feng

原題: Clinical drugs that interact with St. John's wort and implication in drug development.

著者: MisakiNaoko, MaoXia, LinYu-Fung, SugaSechiko, LiGuo-Hui, LiuQiang, ChangYongchang, WangHai, WakuiMakoto, WuJie

原題: Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.

著者: ZünklerBernd J

原題: Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.

著者: KesariAchyut Narayan, GuptaRajesh Kumar, WatalGeeta

原題: Hypoglycemic effects of Murraya koenigii on normal and alloxan-diabetic rabbits.

著者: Granados-SotoV, ArgüellesC F, OrtizM I

原題: The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels.

著者: FedericiMauro, NatoliSilvia, BernardiGiorgio, MercuriNicola B

原題: Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action.

著者: AsvoldB O, JonsbuM, GrillV

原題: [Increased cardiovascular risk in patients with type 2 diabetes treated with sulfonylurea?].

著者: GorskiJ C, HallS D, BeckerP, AffrimeM B, CutlerD L, Haehner-DanielsB

原題: In vivo effects of interleukin-10 on human cytochrome P450 activity.

著者: GribbleF M, TuckerS J, SeinoS, AshcroftF M

原題: Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.

著者: KemnitzJ W, ElsonD F, RoeckerE B, BaumS T, BergmanR N, MeglassonM D

原題: Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.

著者: DogteromP

原題: Development of a simple incubation system for metabolism studies with precision-cut liver slices.

著者: BackD J, HoulgraveR, TjiaJ F, WardS, OrmeM L

原題: Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.

著者: HarrowerA D

原題: Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.

著者: SzórádyI, SántaA

原題: Pharmacogenetically hazardous drugs: a proposed new scoring method.